DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Neulasta (Pegfilgrastim) - Anaemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Anaemia (44)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neulasta (Pegfilgrastim) where reactions include anaemia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 44   Next >>

Possible Neulasta side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-10

Patient: female, weighing 85.0 kg (187.0 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Paclitaxel
    Dosage: 262 mg

Ifosfamide
    Dosage: 9.3 g

Neulasta
    Dosage: 6 mg



Possible Neulasta side effects in male

Reported by a consumer/non-health professional from Germany on 2012-07-09

Patient: male

Reactions: Anaemia, Febrile Neutropenia, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 100 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-04-03

Vincristine
    Dosage: 2 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-04-03

Neulasta
    Dosage: 6 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-04-06
    End date: 2012-04-06

Rituximab
    Dosage: 750 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-02
    End date: 2012-04-02

Cyclophosphamide
    Dosage: 1500 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-04-03

Prednisolone
    Dosage: 500 mg, qd
    Administration route: Oral
    Indication: B-Cell Lymphoma
    Start date: 2012-04-02
    End date: 2012-04-06

Other drugs received by patient: Novalgin / 00169801 /; Morphine Sulfate; Pantoprazole; Dipyrone TAB; Metoclopramide; Acyclovir



Possible Neulasta side effects in 65 year old female

Reported by a physician from Netherlands on 2012-07-06

Patient: 65 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 88 mg, unk
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-25

Vincristine
    Dosage: 2 mg, unk
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-25

Neulasta
    Dosage: 6 mg, unk
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-26

Rituximab
    Dosage: 660 mg, unk
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-25

Cyclophosphamide
    Dosage: 1310 mg, unk
    Indication: Malignant Lymphoid Neoplasm
    Start date: 2012-05-25



Possible Neulasta side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-04

Patient: female, weighing 90.0 kg (198.0 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Topotecan
    Dosage: 1.25 mg, qd
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-28
    End date: 2012-06-01

Neulasta
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Sorafenib; Placebo; Darbepoetin Alfa; Filgrastim



Possible Neulasta side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-04

Patient: female, weighing 84.5 kg (185.9 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neulasta
    Indication: Product Used FOR Unknown Indication

Topotecan
    Dosage: 1.25 mg, qd
    Start date: 2012-03-26
    End date: 2012-06-01

Other drugs received by patient: Sorafenib; Placebo; Filgrastim; Darbepoetin Alfa



Possible Neulasta side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-24

Patient: female, weighing 90.0 kg (198.0 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Topotecan
    Dosage: 1.25 mg, qd
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-28
    End date: 2012-06-01

Neulasta
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Sorafenib; Filgrastim; Darbepoetin Alfa; Placebo



Possible Neulasta side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-24

Patient: female, weighing 84.5 kg (185.9 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Topotecan
    Dosage: 1.25 mg, qd
    Start date: 2012-03-26
    End date: 2012-06-01

Neulasta
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Placebo; Darbepoetin Alfa; Sorafenib; Filgrastim



Possible Neulasta side effects in female

Reported by a physician from Germany on 2012-06-05

Patient: female, weighing 90.0 kg (198.0 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neulasta
    Indication: Product Used FOR Unknown Indication

Topotecan
    Dosage: 1.25 mg, qd
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-28
    End date: 2012-06-01

Other drugs received by patient: Placebo; Filgrastim; Sorafenib; Darbepoetin Alfa



Possible Neulasta side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-04

Patient: female, weighing 84.5 kg (185.9 pounds)

Reactions: Anaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neulasta
    Indication: Product Used FOR Unknown Indication

Topotecan
    Dosage: 1.25 mg, qd
    Start date: 2012-03-26
    End date: 2012-06-01

Other drugs received by patient: Filgrastim; Darbepoetin Alfa; Placebo; Sorafenib



Possible Neulasta side effects in 77 year old male

Reported by a physician from Denmark on 2012-05-29

Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)

Reactions: Fatigue, Malaise, Diarrhoea, Anaemia, Dizziness, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituximab
    Dosage: 750 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Neulasta
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-26

Prednisolone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Cyclophosphamide
    Dosage: 1612 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Doxorubicin HCL
    Dosage: 107 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Other drugs received by patient: Pinex; Sulphamethizole; Valacyclovir Hydrochloride; Omeprazole



Possible Neulasta side effects in

Reported by a physician from Greece on 2012-05-10

Patient: , weighing 40.0 kg (88.0 pounds)

Reactions: Bone Pain, Anaemia, Febrile Neutropenia, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Neulasta



Possible Neulasta side effects in 87 year old female

Reported by a physician from Germany on 2012-05-03

Patient: 87 year old female

Reactions: Seborrhoeic Dermatitis, Coagulopathy, Febrile Infection, Capillary Leak Syndrome, Overdose, Thrombocytopenia, Sinusitis, Anuria, Haematoma, Anaemia, Pancytopenia, Toxicity To Various Agents, Renal Failure Chronic, Pneumonia Bacterial, Rash Erythematous, Sepsis, Acute Hepatic Failure, Leukocytosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Neulasta
    Indication: Leukocytosis

Neupogen
    Dosage: unk
    Indication: Leukopenia
    Start date: 2010-07-10

Neupogen
    Indication: Leukocytosis

Neulasta
    Dosage: 6 mg, unk
    Indication: Leukopenia
    Start date: 2010-07-12
    End date: 2010-07-17

Other drugs received by patient: Cortisone Acetate; Eunerpan; Methotrexate; Vancomycin



Possible Neulasta side effects in 71 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-26

Patient: 71 year old male, weighing 36.2 kg (79.5 pounds)

Reactions: Electrocardiogram ST Segment Depression, White Blood Cell Count Decreased, Blood Urea Increased, Ventricular Hypokinesia, Anaemia, Diastolic Dysfunction, Systolic Dysfunction, Sepsis, Coronary Artery Occlusion, Arteriosclerosis Coronary Artery, Thrombocytopenia, Blood Creatinine Increased, Myocardial Infarction, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neulasta
    Dosage: 6 mg milligram(s), subcutaneous
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-04-02

Cyclophosphamide
    Dosage: 1410 mg milligram(s), intravenous
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-25

Gemcitabine Hydrochloride
    Dosage: 1880 mg milligram(s), intravenous
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-04-01

Prednisone TAB
    Dosage: 100 mg milligram(s), oral
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-29

(Rituximab)
    Dosage: 705 mg milligram(s), intravenous
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-25

Vincristine Sulfate
    Dosage: 2 mg milligram(s), intravenous
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-25

Other drugs received by patient: Metoclopramide; Tramadol HCL; Cotrim



Possible Neulasta side effects in 77 year old male

Reported by a physician from Denmark on 2012-04-26

Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)

Reactions: Fatigue, Malaise, Diarrhoea, Anaemia, Dizziness, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Doxorubicin HCL
    Dosage: 107 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Cyclophosphamide
    Dosage: 1612 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Rituximab
    Dosage: 750 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Prednisolone
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Neulasta
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-26

Other drugs received by patient: Sulphamethizole; Omeprazole; Pinex; Valacyclovir Hydrochloride



Possible Neulasta side effects in male

Reported by a physician from Germany on 2012-04-23

Patient: male

Reactions: Anaemia, Platelet Count Decreased, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Mabthera
    Dosage: 750 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-02
    End date: 2012-04-02

Doxorubicin HCL
    Dosage: 100 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-04-03

Prednisolone
    Dosage: 500 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-02
    End date: 2012-04-06

Vincristine
    Dosage: 2 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-04-03

Neulasta
    Dosage: unk
    Indication: B-Cell Lymphoma
    Start date: 2012-04-06
    End date: 2012-04-06

Cyclophosphamide
    Dosage: 1500 mg, qd
    Indication: B-Cell Lymphoma
    Start date: 2012-04-03
    End date: 2012-04-03

Other drugs received by patient: Acyclovir; Dipyrone TAB; MST-30; Novalgin / 00169801 /; Pantozol / 01263204 /; Paspertin / 00041902 /



Possible Neulasta side effects in 71 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-20

Patient: 71 year old male, weighing 79.7 kg (175.3 pounds)

Reactions: Anaemia, Pyrexia, Dyspnoea Exertional, Fatigue, Sepsis, Chest Pain, Thrombocytopenia, Myocardial Infarction, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Prednisone TAB
    Dosage: 100 mg
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-29

Neulasta
    Dosage: 6 mg
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-04-02

Vincristine
    Dosage: 2 mg
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-25

Cyclophosphamide
    Dosage: 1410 mg
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-25

Gemcitabine
    Dosage: 1880 mg
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-04-01

Rituximab
    Dosage: 705 mg
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-25

Other drugs received by patient: Metoclopramide; Cotrim; Aspirin; Tramadol HCL



Possible Neulasta side effects in male

Reported by a physician from Germany on 2012-04-19

Patient: male

Reactions: Anaemia, Febrile Neutropenia, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1500 mg, qd
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-03
    End date: 2012-04-03

Neulasta
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-06
    End date: 2012-04-06

Doxorubicin HCL
    Dosage: 100 mg, qd
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-03
    End date: 2012-04-03

Vincristine
    Dosage: 2 mg, qd
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-03
    End date: 2012-04-03

Prednisolone
    Dosage: 500 mg, qd
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-02
    End date: 2012-04-06

Other drugs received by patient: Novalgin / 00169801 /; MST-30; Acyclovir; Pantozol / 01263204 /; Mabthera; Paspertin / 00041902 /



Possible Neulasta side effects in 77 year old male

Reported by a physician from Denmark on 2012-04-19

Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)

Reactions: Fatigue, Malaise, Diarrhoea, Anaemia, Febrile Neutropenia, Dizziness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 107 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Rituximab
    Dosage: 750 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Prednisone TAB
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Cyclophosphamide
    Dosage: 1612 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Neulasta
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-26

Other drugs received by patient: Pinex; Omeprazole; Valacyclovir Hydrochloride; Sulphamethizole



Possible Neulasta side effects in 77 year old male

Reported by a physician from Denmark on 2012-04-12

Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)

Reactions: Diarrhoea, Anaemia, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neulasta
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-26

Rituximab
    Dosage: 750 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Doxorubicin HCL
    Dosage: 107 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Prednisone TAB
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Cyclophosphamide
    Dosage: 1612 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Other drugs received by patient: Sulphamethizole; Omeprazole; Codeine SUL TAB; Valacyclovir Hydrochloride



Possible Neulasta side effects in

Reported by a physician from Greece on 2012-04-09

Patient: , weighing 40.0 kg (88.0 pounds)

Reactions: Anaemia, Bone Pain, Febrile Neutropenia, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Neulasta



Possible Neulasta side effects in 47 year old male

Reported by a physician from United Kingdom on 2012-04-04

Patient: 47 year old male, weighing 107.0 kg (235.4 pounds)

Reactions: Fatigue, Anaemia, Neutropenia, Thrombocytopenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Neulasta

Other drugs received by patient: Levomepromazine; Fluconazole; Cisplatin; Gemcitabine; Ondansetron; Ifosfamide; Paclitaxel; Domperidone; Omeprazole



Possible Neulasta side effects in 71 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-30

Patient: 71 year old male, weighing 79.7 kg (175.3 pounds)

Reactions: Electrocardiogram ST Segment Depression, Ventricular Hypokinesia, Platelet Count Increased, Pyrexia, Dyspnoea Exertional, Fatigue, Coronary Artery Occlusion, Chest Pain, Thrombocytopenia, Myocardial Infarction, Blood Creatinine Increased, White Blood Cell Count Decreased, Blood Urea Increased, Anaemia, Coronary Artery Disease, Troponin Increased, Sepsis, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Gemcitabine
    Dosage: 1880 mg, intravenous
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-04-01

Cyclophosphamide
    Dosage: 1410 mg, intravenous
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-25

Neulasta
    Dosage: 6 mg, subcutaneous
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-29

Vincristine
    Dosage: 2 mg, intravenous
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-25

Rituximab (Rituximab)
    Dosage: 705 mg, intravenous
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-25

Prednisone TAB
    Dosage: 100 mg, oral
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-29

Other drugs received by patient: Trimethoprim + Sulfamethoxazole; Tramadol HCL; Metoclopramide



Possible Neulasta side effects in 71 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-28

Patient: 71 year old male, weighing 79.7 kg (175.3 pounds)

Reactions: Anaemia, Pyrexia, Dyspnoea Exertional, Hypokinesia, Fatigue, Chest Pain, Sepsis, Arterial Occlusive Disease, Thrombocytopenia, Myocardial Infarction, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Rituximab
    Dosage: 705 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-25

Gemcitabine
    Dosage: 1880 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-04-01

Cyclophosphamide
    Dosage: 1410 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-25

Neulasta
    Dosage: 6 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-04-02

Tramadol HCL
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Analgesic Therapy
    Start date: 2009-03-25

Prednisone TAB
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-29

Vincristine
    Dosage: 2 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2009-03-25
    End date: 2009-03-25

Other drugs received by patient: Metoclopramide; Aspirin; Cotrim



Possible Neulasta side effects in 77 year old male

Reported by a physician from Denmark on 2012-03-26

Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)

Reactions: Diarrhoea, Anaemia, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Neulasta
    Dosage: 6 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-26

Vincristine
    Dosage: 2 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Doxorubicin HCL
    Dosage: 107 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Prednisone TAB
    Dosage: 100 mg, unk
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Cyclophosphamide
    Dosage: 1612 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Rituximab
    Dosage: 750 mg, unk
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-03-25

Other drugs received by patient: Omeprazole; Codeine SUL TAB; Valacyclovir Hydrochloride; Sulphamethizole



Possible Neulasta side effects in 60 year old male

Reported by a physician from Romania on 2012-03-23

Patient: 60 year old male, weighing 60.0 kg (132.0 pounds)

Reactions: Anaemia, Thrombocytopenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 120 mg, per chemo regim
    Start date: 2012-02-07

Neulasta
    Dosage: 6 mg, after chemo
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-11

Fluorouracil
    Dosage: 1250 mg, 5 times/wk
    Start date: 2012-02-06
    End date: 2012-02-10

Taxotere
    Dosage: 120 mg, per chemo regim
    Start date: 2012-02-07
    End date: 2012-02-07

Other drugs received by patient: Cisplatin; Fluorouracil; Taxotere



Possible Neulasta side effects in 54 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-07

Patient: 54 year old female, weighing 68.1 kg (149.7 pounds)

Reactions: White Blood Cell Count Decreased, Anaemia, Platelet Count Decreased, Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Abraxane
    Dosage: 80 milligram/sq. meter
    Start date: 2011-10-13

Carboplatin
    Dosage: 6 dosage forms
    Indication: Breast Cancer
    Start date: 2011-08-11

Doxorubicin HCL
    Dosage: 60 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-11-10

Cyclophosphamide
    Dosage: 600 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-11-10

Abraxane
    Dosage: 80 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-08-11
    End date: 2011-10-06

Neulasta
    Indication: Chemotherapy

Bevacizumab
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-08-11



Possible Neulasta side effects in 60 year old male

Reported by a physician from Romania on 2012-03-05

Patient: 60 year old male, weighing 60.0 kg (132.0 pounds)

Reactions: Anaemia, Thrombocytopenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cisplatin
    Dosage: 120 mg, per chemo regim
    Start date: 2012-02-07

Taxotere
    Dosage: 120 mg, per chemo regim
    Start date: 2012-02-07
    End date: 2012-02-07

Fluorouracil
    Dosage: 1250 mg, 5 times/wk
    Start date: 2012-02-06
    End date: 2012-02-10

Neulasta
    Dosage: 6 mg, after chemo
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-02-11

Other drugs received by patient: Fluorouracil; Taxotere; Cisplatin



Possible Neulasta side effects in 31 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-02

Patient: 31 year old male

Reactions: Pneumonia, Syncope, Fatigue, Anaemia, Hypotension, Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Methotrexate
    Dosage: 420 mg, unk
    Indication: non-Hodgkin's Lymphoma

Vincristine
    Dosage: 2 mg, unk
    Indication: non-Hodgkin's Lymphoma

Rituxan
    Dosage: 788 mg, unk
    Indication: non-Hodgkin's Lymphoma
    Start date: 2011-09-07

Doxorubicin HCL
    Dosage: 103 mg, unk
    Indication: non-Hodgkin's Lymphoma

Neulasta
    Dosage: 6 mg, unk
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: 6.3 g, unk
    Indication: non-Hodgkin's Lymphoma

Cyclophosphamide
    Dosage: 618 mg, unk
    Indication: non-Hodgkin's Lymphoma

Leucovorin Sodium
    Dosage: 50 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Mesna
    Dosage: 1236 mg, unk
    Indication: non-Hodgkin's Lymphoma

Dexamethasone
    Dosage: 40 mg, unk
    Indication: non-Hodgkin's Lymphoma

Other drugs received by patient: Ciprofloxacin; Valtrex; Medrol; Fluconazole; Voriconazole; Protonix



Possible Neulasta side effects in 44 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-01

Patient: 44 year old female, weighing 119.6 kg (263.1 pounds)

Reactions: White Blood Cell Count Decreased, Diarrhoea, Lymphatic Disorder, Anaemia, Platelet Count Decreased, Febrile Neutropenia, Cardiac Disorder

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Bevacizumab
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Doxorubicin HCL
    Dosage: 10 milligram/sq. meter
    Start date: 2011-03-24

Cyclophosphamide
    Dosage: 600 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-03-24

Abraxane
    Dosage: 80 milligram/sq. meter
    Indication: Breast Cancer
    Start date: 2011-03-24

Neulasta
    Dosage: 6 milligram
    End date: 2011-08-25

Other drugs received by patient: Metoprolol Tartrate; Famotidine; Guaifenesin; Zolpidem; Cefepime; Fluconazole; Prochlorperazine; Bacitracin; Whole Blood; Benzonatate; Acetaminophen



Possible Neulasta side effects in 44 year old female

Reported by a physician from United States on 2012-01-30

Patient: 44 year old female, weighing 119.6 kg (263.1 pounds)

Reactions: White Blood Cell Count Decreased, Type 2 Diabetes Mellitus, Lymphatic Disorder, Anaemia, Pancytopenia, Febrile Neutropenia, Cardiac Disorder, Diarrhoea, Platelet Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Neulasta
    Dosage: 6 milligram
    Indication: Breast Cancer
    End date: 2011-08-25

Abraxane
    Dosage: 80 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Bevacizumab
    Dosage: 10 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Cyclophosphamide
    Dosage: 600 milligram/kilogram
    Indication: Breast Cancer
    Start date: 2011-03-24

Other drugs received by patient: Ambien; Pepcid; Mucinex; Tessalon; Toprol-XL; Bacitracin; Prochlorperazine; Armodafinil; Acetaminophen; Cefepime



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017